Entering text into the input field will update the search result below

Pfizer, Inc. (PFE) CEO Albert Bourla on Q1 2021 Results - Earnings Call Transcript

May 04, 2021 7:08 PM ETPfizer Inc. (PFE)
SA Transcripts profile picture
SA Transcripts

Pfizer, Inc. (NYSE:PFE) Q1 2021 Earnings Conference Call May 4, 2021 10:00 AM ET

Company Participants

Charles Triano - SVP, IR

Albert Bourla - Chairman & CEO

Frank D'Amelio - CFO & EVP, Global Supply

Mikael Dolsten - Chief Scientific Officer & President, Worldwide Research, Development & Medical

Conference Call Participants

Louise Chen - Cantor Fitzgerald & Co.

Terence Flynn - Goldman Sachs Group

Geoffrey Porges - SVB Leerink

Stephen Scala - Cowen and Company

Vamil Divan - Mizuho Securities

Umer Raffat - Evercore ISI

Timothy Anderson - Wolfe Research

Navin Jacob - UBS


Good day, everyone, and welcome to Pfizer's First Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

Charles Triano

Thank you, Operator. Good morning, and thanks for joining us today to review Pfizer's first quarter 2020 results and financial guidance update as well as other relevant business topics. I'm joined today as usual by our Chairman and CEO, Dr. Albert Bourla; Frank D'Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development and Medical; Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; John Young, our Chief Business Officer; and Doug Lankler, General Counsel.

The slides and the accompanying remarks that will be presented on this call were posted to our website earlier this morning and are available at pfizer.com/investors. You'll see here, on Slide 3, our disclaimer regarding forward-looking statements we will make during this call regarding, among other topics, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline and in-line products, which are subject to risks and uncertainties as well as the use of non-GAAP financial information.

Additional information regarding

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About PFE

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on PFE

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.